ABSTRACT
OBJECTIVES AND DESIGN: We investigated the effects of microbial components on the uptake of microbes by mast cells (MCs), and studied the change in cytokine production in MCs after bacterial uptake. MATERIAL OR SUBJECTS: LAD2 human mast cells, cord-blood and peripheral-blood derived MCs were employed to analyze their surface molecule expression and cytokine generation by flow cytometry. Bacterial internalization in these MCs was observed by confocal microscopy and flow cytometry. RESULTS: Complement receptor 3 expression was augmented by LTA but not by PGN or 3CpG-oligodeoxynucleotide. LTA also enhanced the uptake of opsonized bacteria (over twofold augmentation). After bacterial uptake, MCs augmented the production of chemoattractant cytokines for neutrophils, while Th1 and Th2 cytokine production showed little or no change. CONCLUSIONS: LTA increases the capability of the MC as a sentinel in the host immune response, and some bacterial components direct human MC function towards innate immunity after pathogen infection.
Subject(s)
Lipopolysaccharides/pharmacology , Mast Cells , Staphylococcus aureus/metabolism , Teichoic Acids/pharmacology , Animals , CD11b Antigen/immunology , Cells, Cultured , Chemokines/immunology , Cytokines/immunology , Endocytosis/physiology , Humans , Macrophage-1 Antigen/immunology , Mast Cells/drug effects , Mast Cells/immunology , Mast Cells/physiology , Peptidoglycan/immunology , Receptors, IgG/immunology , Toll-Like Receptor 2/genetics , Toll-Like Receptor 2/immunology , Toll-Like Receptor 9/genetics , Toll-Like Receptor 9/immunologyABSTRACT
BACKGROUND: FcepsilonRI on the surface of mast cells (MCs) plays a central role in allergic responses. Recent evidence shows that exposure to microbial components corresponds with a significant reduction in the risk for allergic diseases. Although many reports suggest that this is due to changes in T-cell functions, how MC functions are altered by bacterial infection remains unknown. OBJECTIVE: We sought to elucidate the effect of bacterial infection on MC function and expression of Fc receptors, such as FcepsilonRI. METHODS: Isolated human pulmonary MCs and a human MC line (LAD2) were stimulated with bacterial components, and the function and surface expression of Fc receptors were measured. RESULTS: Lipoteichoic acid (LTA) and peptidoglycan, but not LPS, flagellin, or 3CpG-oligodeoxynucleotide, reduced the expression of FcepsilonRI on LAD2 cells. An antibody to Toll-like receptor (TLR) 2 partially blocked the effect of LTA but not peptidoglycan. Both LTA and peptidoglycan reduced MC degranulation caused by an antigen-specific IgE. Furthermore, exposure of pulmonary MCs to LTA reduced both FcepsilonRI expression and IgE-induced degranulation. None of the bacterial components affected the expression of other Fc receptors, such as Fcgamma receptors or Fcalpha receptor I. CONCLUSIONS: Our results indicate that LTA reduces the surface expression of FcepsilonRI through TLR2 and suggests that TLR2 ligands could be used as a novel therapy for controlling allergic disorders. CLINICAL IMPLICATIONS: By knowing how bacterial components modulate MC function, we can expand our possibilities for therapeutic interventions of allergic diseases.
Subject(s)
Down-Regulation/physiology , Lipopolysaccharides/pharmacology , Mast Cells/metabolism , Receptors, IgE/metabolism , Teichoic Acids/pharmacology , Toll-Like Receptor 2/physiology , Cell Degranulation/drug effects , Cell Line , Cell Membrane/metabolism , Dose-Response Relationship, Drug , Humans , Ligands , Lipopolysaccharides/administration & dosage , Lung/cytology , Mast Cells/cytology , Mast Cells/physiology , Peptidoglycan/administration & dosage , Peptidoglycan/pharmacology , RNA, Messenger/metabolism , Receptors, IgE/genetics , Teichoic Acids/administration & dosage , Toll-Like Receptors/metabolismABSTRACT
Patients with high serum immunoglobulin E levels were reported to be protected against sudden death during acute myocardial infarction. The protection mechanism might be attributed to the facilitation of histamine release from sensitized mast cells; however, this remains to be clarified. In this study, we examined the influence of sensitization on ventricular fibrillation (VF) induced by myocardial hypoxia/reoxygenation (H/R). Guinea pigs were actively sensitized by subcutaneous injection of ovalbumin in Bordetella pertussis vaccine. Hearts isolated from non-sensitized and sensitized guinea pigs were subjected to 30-min hypoxia / 30-min reoxygenation using a Langendorff apparatus. The amount of histamine released in the sensitized guinea-pig hearts was elevated, and the duration of VF was found to be reduced. The treatment with a histamine H2-receptor antagonist inhibited the reduction of VF duration. Treatment of the non-sensitized hearts with the histamine H2-receptor agonist resulted in the decrease of VF duration to the same level as that in the sensitized hearts. In conclusion, these results suggest that the risk of sudden death during myocardial H/R may be attenuated in the sensitized hearts and that histamine H2-receptor activation due to the released histamine may be involved in the protective effect.
Subject(s)
Histamine Agonists/pharmacology , Myocardial Reperfusion Injury/complications , Receptors, Histamine H2/drug effects , Ventricular Fibrillation/etiology , Ventricular Fibrillation/prevention & control , Adrenergic beta-Antagonists/pharmacology , Animals , Atenolol/pharmacology , Cytoplasmic Granules/drug effects , Dimaprit/analogs & derivatives , Dimaprit/pharmacology , Electrocardiography/drug effects , Enzyme Inhibitors/pharmacology , Female , Guinea Pigs , Histamine/pharmacology , Histamine Antagonists/pharmacology , Histamine N-Methyltransferase/antagonists & inhibitors , Histamine Release/drug effects , Immunoglobulin E/metabolism , In Vitro Techniques , Mast Cells/drug effects , PerfusionABSTRACT
To elucidate the details of tryptase release from the heart during ischemia-reperfusion (I/R), we attempted the enzymatic measurement of tryptase release from the isolated guinea pig heart perfused by the Langendorff mode I/R model. Tryptase-like activity in the effluent was monitored by the hydrolysis of L-Pyr-Gly-Arg-MCA. Tryptase-like protease and histamine were rapidly released from heart during ischemia within 10 min. After reperfusion, tryptase-like protease levels decreased, achieving stabilization. The tryptase-like protease activity in the effluent was inactivated by serine protease inhibitors. The pattern of inhibition was similar to those of guinea pig and human lung tryptase. In conclusion, tryptase was released into the coronary effluent during ischemia, but not during reperfusion in guinea pig heart.
